Home
Welcome to the homepage of the Hopkins Medical Device Network.
Hopkins Medical Device Network (HMDN) is a student-run organization at the Johns Hopkins University that provides medical device development opportunities outside of the Design Team course, which is run by the Whitaker Biomedical Engineering Department. HMDN focuses on the educational aspect of medical device research and development, as well as team work and management. HMDN also encourages generating creative and innovative solutions to current medical problems. In addition, the organization facilitates networking with engineers, doctors, IP lawyers, entrepreneurs and venture capitalists. Such opportunities are not currently widespread at Johns Hopkins University, and there is a growing demand for an organization to provide them.
Our mission is to promote the development of medical device technologies at JHU by:
- Facilitating networking opportunities with students and professionals with similar interests
- Advising and supporting students engaged in research and the development of medical devices
- Connecting students with researchers, industry representatives and potential clients
- Educating and preparing students for the process of medical device development
by
Bryce Chiang on
March 4th, 2009

Hopkins Medical Device Network presents:
Dr. Daniel Schultz, Director of the FDA’s Center for Radiological Devices and Health
Nancy Pluhowski, the Director of the Medical Device Fellowship program
Courtney Harper of the Office of InVitro Diagnostic Device Safety and Evaluation
Regulating Innovation: The Director’s Take on How to Get Your Device FDA Approved
| Date: |
Tuesday, March 10th 2009 |
| Time: |
6 pm to 7 pm (Exclusive networking event to follow) |
| Location: |
JHU Homewood Campus, Computational Science & Engineering Building (CSEB) Auditorium |
| Cost: |
FREE, LIGHT REFRESHMENTS WILL BE SERVED |
Come join HMDN as it hosts Dr. Daniel Schultz, Director of the FDA’s Center for Radiological Devices and Health, along with Nancy Pluhowski, the Director of the Medical Device Fellowship program and Courtney Harper of the Office of InVitro Diagnostic Device Safety and Evaluation. Dr. Schultz will speak on the medical device approval process along with what it takes to successfully bring a novel medical device to market. Courtney Harper will explain current trends in diagnostic laboratory tests, while Nancy Pluhowski will talk about employment opportunities at the FDA.
Dr. Dan Schultz holds a bachelor’s degree in political science from the City College of New York and received his medical degree from the University of Pittsburgh in 1974. He is board certified in general surgery and family practice. Dr. Schultz entered the Commissioned Corps of the US Public Health Service in 1974, where he served in the PHS Indian Health Service as a hospital clinical director and a surgical resident. In 1983 he was appointed Chief of Surgery at the Indian Health Service Hospital in Santa Fe, New Mexico, a post he held for 11 years. In 1994 Dr. Schultz joined the Center for Devices and Radiological Health of the FDA, where he served in CDRH’s Office of Device Evaluation, first as a medical officer, then a Division Director, then the Office’s Deputy Director and finally its Director. He was promoted to Director of CDRH in 2004.
_______________________________________________
Interested in networking and job opportunities? Meet the Director of the FDA Internship and Fellowship program.
Sign up now for an exclusive meet and greet opportunity with our guests from the F.D.A.
RSVP to hmdn@jhu.edu to reserve your spot, $10 at door, limited space for the meet and greet
Category:
Uncategorized |
No Comments
by
Bryce Chiang on
February 11th, 2009
Competitive Intelligence: Do you really know what you’re getting into?
Hopkins Medical Device Network presents David Cranmer, President of Phase 3 Consulting LLC
|
Date:
|
Thursday, February 26th 2009
|
|
Time:
|
6 pm to 7 pm (Exclusive networking event to follow)
|
|
Location:
|
CSEB Auditorium |
|
Cost:
|
FREE
|
Competitive intelligence is part of the knowledge you need to compete successfully. This is especially true when you’re in start-up mode – you need to know who’s selling similar products and services to the customers you’re after. In this workshop, we’ll discuss what competitive intelligence is, how you get it, and what you do with it. You will leave with specific tools and methods to collect information about specific competitors and their products and services, compare it to your offerings, decide how different (or not) you really are, and determine what you are going to do to be different and distinctive.
Dave Cranmer is the President and Managing Director of Phase 3 Consulting LLC. The company provides management consulting, business-to-business marketing, and technology management and evaluation services. Clients include small technology-based companies (medical devices, fire safety) as well as Fortune 500 companies. Specific projects range from first-look market research for a new product to preparing a company to raise capital including financial projections, historical accounting statements and business plan review. Dave has worked for government, non-profit and for-profit companies in both technical and non-technical fields. He has a Ph.D. and S.M. from MIT, a B.S. from Penn State and an MBA from the Edinburgh Business School of Heriot-Watt University.
_____________________________________________________________________________
Interested in networking and job opportunities?
Sign up now for an exclusive meet and greet opportunity with David Cranmer
RSVP to hmdn@jhu.edu to reserve your spot, $10 at door, limited space
Category:
Uncategorized |
No Comments
by
Bryce Chiang on
February 11th, 2009
Volume 1: Issue 14 02/09/09
Researchers using some of the same techniques as cancer cells, have been able to immortalize liver cells and create a bedside unit which may be used as a liver replacement. The researchers at the University of Michigan expect this can be used as a temporary replacement for a liver while awaiting a true liver transplant. Their specific cell lines allow them to use the cells in such innovative ways.
Surgeons working on the battle field to quickly stabilize a patient are often under the most pressure from external threats, but are responsible for saving many lives. To help protect those surgeons, Carnegie Mellon University has invented a wireless robotic arm which can monitor and stabilize a patient’s condition while keeping the operator at a fair distance.
Stanford has decided to make a set of talks about the future of health and healthcare publicly available on YouTube. Stanford researchers are allowed the opportunity to make their own quasi-TED talks to faculty and students for 18 minutes at Stanford about the future of health. Some topics include brain-computer interfaces, medical imaging, and worldwide pandemics.
Category:
Digest |
No Comments
by
Bryce Chiang on
February 2nd, 2009
Volume 1: Issue 13 02/02/09
A new implant developed at Harvard University has shown promise in training immune cells to attack cancerous cells. This new method, coined immunotherapy, formerly required researchers to excise the dendritic cells, activate them, and reinsert them which was only somewhat successful. The implant developed at Harvard first releases cytokines to attract dendritic cells, then activates them with antigens and DNA fragments.
Cleveland clinic has named Cambridge-Endo’s articulating laproscopic instrument a game changer in the field of surgery because it allows single access point minimally invasive surgeries. Rather than conventional laproscopic surgeries which require several small incisions, the innovative articulating instrument has seven degrees of freedom allowing the surgeon to perform complicated procedures through the navel, leaving a single hidden scar.
A new wrist-watch sized device has had promising results in trials at USF in detected dementia earlier than conventional methods. Conventional methods rely on surveys, which are often inaccurate, but this new method uses RFID transceivers and computerized triangulation to measure the walking patterns of elderly, detecting sharp veering, wandering, and pausing which early indicators of dementia.
Category:
Digest |
No Comments
by
Bryce Chiang on
January 27th, 2009
Volume 1: Issue 12 01/26/09
Humans have scored another point against bacteria in the war between bugs and antibiotics. Researchers have found a new chemical extracted from Hydra which is capable of killing gram-positive and gram-negative bacteria, including some antibiotic-resistant bacteria.
Sir Terry Prachett, renowned science fiction author, is one of the first patients to test Dr. Dougal’s Alzheimer’s helmet. This helmet uses sharp bursts of infrared light to encourage brain cell growth. Testing has shown a small but insignificant improvement in the small sample.
Amazingly, this isn’t a riff on the sci-fi author article. Researchers at Monash University have develped a Piezo-electric motor that could be used to propel a microbot using a flagella. The microscopic robots would be used in lieu of interventional techniques.
Category:
Digest |
No Comments